Irregular heart rhythm notification added to electrocardiogram monitoring, helping users seamlessly track abnormal heart rhythms
Samsung Electronics today announced that the Irregular Heart Rhythm Notification (IHRN) feature1 of the Samsung Health Monitor app2 has received FDA clearance. Together with the app’s existing on-demand Electrocardiogram (ECG) function,3 the IHRN feature proactively monitors heart rhythms suggestive of atrial fibrillation (AFib), right from their wrist.
“We’re excited to announce that Irregular Heart Rhythm Notification, designed to help millions of people around the world who may not be aware of a potential heart risk, has been cleared by the FDA,” said Hon Pak, Vice President and Head of the Digital Health Team, MX Business at Samsung Electronics. “This is yet another example of how Samsung prioritizes proactive safety solutions and enables users to receive a more holistic understanding of their cardiovascular and overall health.”
Cardiovascular disease remains one of the world’s leading causes of death and AFib — a type of arrhythmia — is widely considered a warning sign for major cardiovascular issues that can increase the risk of stroke, heart failure and other cardiovascular complications.
